XmAb942

· Xencor, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XmAb942, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis [Phase 1, Phase 2]